Safety and tolerability of COVID-19 vaccines in patients with cancer: a single center retrospective analysis A Nuzzo, S Manacorda, E Sammarco, A Sbrana, S Bazzurri, F Paolieri, ... Vaccines 10 (6), 892, 2022 | 1 | 2022 |
The treatment of Advanced Melanoma: Current approaches and new challenges A Boutros, E Croce, M Ferrari, R Gili, G Massaro, R Marconcini, L Arecco, ... Critical Reviews in Oncology/Hematology, 104276, 2024 | | 2024 |
1199P MAVERIC: Phase II randomized study of everolimus as maintenance therapy for metastatic neuroendocrine neoplasms (mNEN) with pulmonary or gastroenteropancreatic (GEP … L Antonuzzo, S Pillozzi, R Marconcini, F Spada, F Gelsomino, V Amoroso, ... Annals of Oncology 34, S707-S708, 2023 | | 2023 |
FIRST-LINE COMBINATION THERAPIES FOR ADVANCED RENAL CELL CARCINOMA (ARCC): AN ITALIAN SINGLE-CENTRE REAL-WORLD CLINICAL EXPERIENCE C Mercinelli, G Massaro, A Bonato, A Nuzzo, S Manacorda, E Sammarco, ... ANTICANCER RESEARCH 42 (10), 5144-5145, 2022 | | 2022 |
Comparison between first line target therapy and immunotherapy in different prognostic categories of BRAF mutant metastatic melanoma patients: an Italian Melanoma Intergroup study R Marconcini, P Fava, A Nuzzo, S Manacorda, M Ferrari, F De Rosa, ... Frontiers in Oncology, 3459, 2022 | | 2022 |
Safety and tolerability of COVID-19 vaccines in patients with cancer: a single center retrospective analysis (preprint) A Nuzzo, S Manacorda, E Sammarco, A Sbrana, S Bazzurri, F Paolieri, ... | | 2022 |
750P Safety and efficacy of platinum desensitization treatment in patients with ovarian cancer and platinum hypersensitivity A Nuzzo, S Manacorda, F Paolieri, A Sbrana, S Bazzurri, E Sammarco, ... Annals of Oncology 32, S743-S744, 2021 | | 2021 |